DAB.bio is revolutionizing industrial biomanufacturing with its FAST™ platform technology. FAST™ enables continuous fermentation, unlocking performance not achievable with conventional fermentation processes and substantially reducing product COGS at improved capex efficiency. By licensing DAB.bio’s FAST™ technology, manufacturers achieve competitive cost-levels and reduce required investments. FAST™ is agnostic of process, product or microbial host: FAST™ can among other strongly impact the production cost of chemicals, lipids, alternative proteins, enzymes and biofuels. By breaking the cost barrier in biomanufacturing, DAB.bio aims to accelerate the bioeconomy towards a net-zero future.